|
Illumina, Inc. - Company Profile Snapshot
| Company Profile: |
Illumina, Inc. |
| Ticker: |
ILMN |
| Exchanges: |
NAS |
| 2008 Sales: |
573,230,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
1536 |
Business Description
Illumina, Inc.. The Group's principal activity is to design and develop next-generation tools for the large-scale analysis of genetic variation and function. The Group's patented Bead Array technology uses fiber optics to achieve a level of array miniaturization that allows for a new scale of experimentation. The tools provide information that could be used by life sciences and pharmaceutical companies to improve drugs and therapies, customize diagnoses and treatment and cure diseases. The Group's complementary Oligator technology permits parallel synthesis of the millions of different pieces of DNA necessary to perform large-scale genetic analysis on arrays. Illumina, Arrays of Arrays, BeadArray, GoldenGate and Oligator are the Group's Trademarks.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
